Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $15.7350 (1.12%) ($15.0000 - $16.3900) on Wed. Nov. 11, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.86% (three month average) | RSI | 56 | Latest Price | $15.7350(1.12%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 2% a day on average for past five trading days. | Weekly Trend | ATRA advances 1.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Rotation from value to growth for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) IBB(45%) ARKG(44%) ARKK(43%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -1.93% in a week (0% probabilities). VIXM(-32%) VXX(-26%) UNG(-11%) UUP(-8%) TLT(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.93% (StdDev 3.86%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $14.59(7.85%) | 10 Day Moving Average | $14(12.39%) | 20 Day Moving Average | $14.04(12.07%) | To recent high | -0.9% | To recent low | 32% | Market Cap | $1.169b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |